痛点注射美洛昔康治疗跟痛症的临床观察  

Efficacy of puncta dolorosa injection meloxicam in patients with heel pain

作　　者：薄存菊[1] 卢振和[1] 

机构地区：[1]广州医学院第二附属医院疼痛科,510260

出　　处：《中国实用医药》2012年第18期11-12,共2页China Practical Medicine

摘　　要：目的观察美洛昔康注射液(Boehringer Ingelheim France,15mg/ml)局部痛点注射用于跟痛症的疗效,并与醋酸泼尼松(浙江仙琚制药股份有限公司制造,25mg/ml)进行疗效对比。方法选择门诊跟痛症患者50例,采用随机单盲的方法,将患者分为美洛昔康组和醋酸泼尼松组,分别于足跟痛点分别注射美洛昔康注射液15mg及醋酸泼尼松25mg,每隔3d注射一次,连续注射3次。治疗后随访3个月,对美洛昔康和醋酸泼尼松在疗效和不良反应上进行对比观察。结果美洛昔康组受试者注射后有效病例(包括显效和有效病例数)20例,优良率80%;醋酸泼尼松组受试者注射后有效病例21例,优良率84%。两组患者注药后疼痛缓解优良率比较,无明显统计学意义(P>0.05)。结论美洛昔康注射液局部注射用于跟痛症患者可与醋酸泼尼松取得相似的疗效,其安全性及不良反应均优于醋酸泼尼松。Objective Observe the efficacy of puncta dolorosa injection meloxieam in patients with heel pain：comparison with puncta dolorosa injection prednisone acetate. Methods A randomized, hydrocorti- sone acetate-controlled prospective trim was undertaken in 50 patients with heel pain. The patient was injected with meloxicam or hydrocortisone acetate in the puncta dolorosa for 3 times at intervals of 3 days respectively. The effect and adverse reaction were analyzed. Results The rate of fineness in meloxicam group was 80% , and the fineness rate of the prednisone acetate was 84%. There＇s no difference between the groups. Conclusion The efficacy of puncta dolorosa injection meloxicam was so similar to the intramuscular prednisone acetate.

关 键 词：跟痛症 美洛昔康注射液 醋酸泼尼松 痛点注射 

分 类 号：R681.8[医药卫生—骨科学]